Curcumin and Curcumol Inhibit NF- κ B and TGF- β 1/Smads Signaling Pathways in CSE-Treated RAW246.7 Cells
- PMID: 31007701
- PMCID: PMC6441512
- DOI: 10.1155/2019/3035125
Curcumin and Curcumol Inhibit NF- κ B and TGF- β 1/Smads Signaling Pathways in CSE-Treated RAW246.7 Cells
Abstract
E-Zhu (Curcuma zedoaria) is known as a classical traditional Chinese medicine and widely used in the treatment of cancers, cardiovascular disease, inflammation, and other diseases. Its main components include curcumol and curcumin, which have anti-inflammatory and antifibrosis effects. Here we established an in vitro inflammatory injury model by stimulating RAW246.7 cells with cigarette smoke extract (CSE) and detected the intervention effects of curcumin and curcumol on CSE-treated Raw246.7 macrophage cells to explore whether the two compounds inhibited the expression of inflammatory cytokines by inhibiting the NF-κB signaling pathway. We detected the antifibrosis effects of curcumin and curcumol via TGF-β 1/Smads signaling pathways. The model of macrophage damage group was established by CSE stimulation. Curcumol and curcumin were administered to Raw246.7 macrophage cells. The efficacy of curcumol and curcumin was evaluated by comparing the activation of proinflammatory factors, profibrotic factors, and NF-κB and TGF-β 1/Smads signaling pathway. In addition, CSE-treated group was employed to detect whether the efficacy of curcumol and curcumin was dependent on the NF-κB signaling via the pretreatment with the inhibitor of NF-κB. Our findings demonstrated that curcumol and curcumin could reduce the release of intracellular ROS from macrophages, inhibit the NF-κB signaling pathway, and downregulate the release of proinflammatory factor. Curcumol and curcumin inhibited the TGF-β 1/Smads signaling pathway and downregulated the release of fibrotic factors. Curcumin showed no anti-inflammatory effect in CSE-treated cells after the inhibition of NF-κB. Curcumol and curcumin showed an anti-inflammatory effect by inhibiting the NF-κB signaling pathway.
Figures











Similar articles
-
Curcumin inhibits cigarette smoke-induced inflammation via modulating the PPARγ-NF-κB signaling pathway.Food Funct. 2019 Dec 11;10(12):7983-7994. doi: 10.1039/c9fo02159k. Food Funct. 2019. PMID: 31773117
-
The main active components of Curcuma zedoaria reduces collagen deposition in human lung fibroblast via autophagy.Mol Immunol. 2020 Aug;124:109-116. doi: 10.1016/j.molimm.2020.05.017. Epub 2020 Jun 15. Mol Immunol. 2020. PMID: 32554101
-
HBOA ameliorates CCl4-incuded liver fibrosis through inhibiting TGF-β1/Smads, NF-κB and ERK signaling pathways.Biomed Pharmacother. 2019 Jul;115:108901. doi: 10.1016/j.biopha.2019.108901. Epub 2019 May 9. Biomed Pharmacother. 2019. PMID: 31079002
-
Therapeutic Effects of Curcumol in Several Diseases; An Overview.Nutr Cancer. 2021;73(2):181-195. doi: 10.1080/01635581.2020.1749676. Epub 2020 Apr 14. Nutr Cancer. 2021. PMID: 32285707 Review.
-
Role of Curcuma longae Rhizoma in medical applications: research challenges and opportunities.Front Pharmacol. 2024 Aug 6;15:1430284. doi: 10.3389/fphar.2024.1430284. eCollection 2024. Front Pharmacol. 2024. PMID: 39170702 Free PMC article. Review.
Cited by
-
13C CPMAS NMR as an Alternative Method to Verify the Quality of Dietary Supplements Containing Curcumin.Molecules. 2023 Apr 13;28(8):3442. doi: 10.3390/molecules28083442. Molecules. 2023. PMID: 37110676 Free PMC article.
-
Qilongtian ameliorate bleomycin-induced pulmonary fibrosis in mice via inhibiting IL-17 signal pathway.Sci Rep. 2023 Apr 12;13(1):6002. doi: 10.1038/s41598-023-31439-5. Sci Rep. 2023. Retraction in: Sci Rep. 2023 Jul 12;13(1):11263. doi: 10.1038/s41598-023-38495-x. PMID: 37045911 Free PMC article. Retracted.
-
Mobilizing endogenous neuroprotection: the mechanism of the protective effect of acupuncture on the brain after stroke.Front Neurosci. 2024 Apr 25;18:1181670. doi: 10.3389/fnins.2024.1181670. eCollection 2024. Front Neurosci. 2024. PMID: 38737099 Free PMC article. Review.
-
Phytochemicals in the treatment of inflammation-associated diseases: the journey from preclinical trials to clinical practice.Front Pharmacol. 2023 May 9;14:1177050. doi: 10.3389/fphar.2023.1177050. eCollection 2023. Front Pharmacol. 2023. PMID: 37229273 Free PMC article. Review.
-
Phytochemicals in Cancer Chemoprevention: Preclinical and Clinical Studies.Cancer Control. 2024 Jan-Dec;31:10732748241302902. doi: 10.1177/10732748241302902. Cancer Control. 2024. PMID: 39629692 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources